Drug Type Small molecule drug |
Synonyms Aldenon, Aldenonc, IY-NT-R + [5] |
Target |
Mechanism Proton pump inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date CN (11 Dec 2007), |
Regulation- |
Molecular FormulaC19H18N4O2S |
InChIKeyHRRXCXABAPSOCP-UHFFFAOYSA-N |
CAS Registry172152-36-2 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | Ilaprazole |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Esophagitis, Peptic | ID | 27 Sep 2022 | |
Gastroesophageal Reflux | CN | 16 Apr 2015 | |
Erosive esophagitis | KR | 28 Oct 2008 | |
Stomach Ulcer | KR | 28 Oct 2008 | |
Duodenal Ulcer | CN | 11 Dec 2007 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Peptic Ulcer Hemorrhage | Phase 1 | CN | 18 Jan 2014 | |
Peptic Ulcer Hemorrhage | Phase 1 | CN | 18 Jan 2014 | |
Helicobacter pylori infection | IND Approval | CN | 01 Nov 2022 | |
Non-erosive gastro-esophageal reflux disease | IND Approval | CN | 01 Nov 2022 |
Phase 4 | 176 | mnduppwsme(uazdbhimou) = tnvgcpmckw dcljguubgs (tsfhexbhty ) View more | Positive | 01 May 2019 | |||
mnduppwsme(uazdbhimou) = qvnmvuaaox dcljguubgs (tsfhexbhty ) View more | |||||||
NCT02860624 (Pubmed) Manual | Phase 3 | 537 | hlnvkidpdy(igddcyslxe) = rycorujzfq unkrhxnjhu (pxdfhehtyl ) View more | Similar | 01 May 2018 | ||
hlnvkidpdy(igddcyslxe) = mpvhxvnnfe unkrhxnjhu (pxdfhehtyl ) View more | |||||||
Phase 2 | - | dihsotzplv(ymcrwxfmmu) = nxftexfnvn hmldgevaoz (mpopymnjvn, (86.73%)) View more | - | 01 Dec 2016 | |||
dihsotzplv(ymcrwxfmmu) = qnxylqolnl hmldgevaoz (mpopymnjvn, (81.40%)) View more | |||||||
Phase 3 | 494 | nooerlrbkj(rsqqkkqbiv) = owogwhaxey zjqqywybov (kiorwcocnc ) | Positive | 01 Jan 2012 | |||
nooerlrbkj(rsqqkkqbiv) = qohxwjpojz zjqqywybov (kiorwcocnc ) |